AACR Virtual Meeting: COVID-19 and Cancer
February 3-5, 2021
Program Committee Chair
E. John Wherry, University of Pennsylvania, Philadelphia, Pennsylvania
Dafna Bar-Sagi, NYU Langone Health, New York, New York
Anna D. Barker, Ellison Institute for Transformative Medicine, Los Angeles, California
Fabrice Barlesi, INSERM U1030 – Gustave Roussy Institute, Villejuif, France
Deepta Bhattacharya, University of Arizona Cancer Center, Tuscon, Arizona
John M. Carethers, University of Michigan, Ann Arbor, Michigan
Robert L. Ferris, University of Pittsburgh Hillman Cancer Center, Pittsburgh, Pennsylvania
Patrick D. Hsu, University of California, Berkeley, Berkeley, California
Ross L. Levine, Memorial Sloan Kettering Cancer Center, New York, New York
Ana Maria Lopez, Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, Pennsylvania
Miriam Merad, Icahn School of Medicine at Mount Sinai, New York, New York
Jeffrey S. Morris, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania
Solange Peters, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland
Antoni Ribas, University of California Los Angeles (UCLA), Jonsson Comprehensive Cancer Center (JCCC), Los Angeles, California
Louis M. Staudt, National Cancer Institute, Bethesda, Maryland
David A. Tuveson, Cold Spring Harbor Laboratory, Cold Spring Harbor, New York
Louis P. Voigt, Memorial Sloan Kettering Cancer Center, New York, New York
This AACR virtual meeting will focus on the presentation of emerging data in basic, clinical, translational, and epidemiological research related to COVID-19 and cancer. Advances made since the first AACR meeting on this topic in July 2020 will be covered through a mix of keynote lectures, panel discussions, scientific symposia, and poster sessions. The impact of COVID-19 as a worldwide pandemic has been called my many as a once in a century event – impacting nearly every country on the globe.
COVID-19 continues to impact cancer care and healthcare professionals continue to adapt to minimize the negative ramifications related to cancer outcomes and psychosocial disorders due to the pandemic. Unfortunately, COVID-19 has had a disproportionate impact on certain ethnic and socioeconomic sectors of society, shining a spotlight on health care disparities.
This virtual meeting will not only provide updates on topics covered in July 2020, but will also address new areas such as artificial intelligence, data science, new agent development, and survivorship and policy issues that are crucial elements in the struggle against this virus.
Attendee registration includes access to all sessions presented during the live February 3-5, 2021 program and to the on-demand recordings and poster presentations. On-demand materials will be available for 90 days starting approximately 5-7 business days after the live program ends.
Janssen Research and Development, LLC
PROFESSIONAL EDUCATIONAL GRANTS
Daiichi Sankyo, Inc.
Continuing Medical Education Activity AMA PRA Category 1 CreditsTM available